As of 2025-07-09, the Intrinsic Value of Orient Bio Inc (002630.KS) is 679.70 KRW. This 002630.KS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 795.00 KRW, the upside of Orient Bio Inc is -14.50%.
The range of the Intrinsic Value is 514.22 - 1,049.09 KRW
Based on its market price of 795.00 KRW and our intrinsic valuation, Orient Bio Inc (002630.KS) is overvalued by 14.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 514.22 - 1,049.09 | 679.70 | -14.5% |
| DCF (Growth 10y) | 535.82 - 1,013.29 | 685.19 | -13.8% |
| DCF (EBITDA 5y) | 650.40 - 846.45 | 774.94 | -2.5% |
| DCF (EBITDA 10y) | 659.08 - 895.29 | 792.59 | -0.3% |
| Fair Value | 381.83 - 381.83 | 381.83 | -51.97% |
| P/E | 308.82 - 3,274.14 | 1,462.36 | 83.9% |
| EV/EBITDA | 355.51 - 735.77 | 507.60 | -36.2% |
| EPV | 346.46 - 467.46 | 406.96 | -48.8% |
| DDM - Stable | 127.31 - 364.33 | 245.82 | -69.1% |
| DDM - Multi | 1,129.48 - 2,532.16 | 1,564.24 | 96.8% |
| Market Cap (mil) | 94,271.10 |
| Beta | 0.39 |
| Outstanding shares (mil) | 118.58 |
| Enterprise Value (mil) | 90,702.42 |
| Market risk premium | 5.82% |
| Cost of Equity | 8.09% |
| Cost of Debt | 4.25% |
| WACC | 7.96% |